[1] DEFEUDIS F V. BILOBALIDE AND NEUROPROTECTION[J]. Pharmacological research, 2002, 46 6: Pages 565-568. DOI:
10.1016/s1043-6618(02)00233-5[2] CORNELIA KIEWERT . Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide[J]. Brain Research, 2008, 1201: Pages 143-150. DOI:
10.1016/j.brainres.2008.01.052[3] DOROTHEE LANG . Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo[J]. Brain Research, 2011, 1425: Pages 155-163. DOI:
10.1016/j.brainres.2011.10.005[4] AIK JIANG LAU. Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor.[J]. Drug Metabolism and Disposition, 2012, 40 1: 178-186. DOI:
10.1124/dmd.111.042879[5] Y DENG. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.[J]. Xenobiotica, 2008, 38 5: 465-481. DOI:
10.1080/00498250701883233